Iodide

Iodide

SCHEMBL6113178

Cc1cccc(C(=O)O)c1C.I

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.59
ALDH1A1 P00352 5/20 0.63
KDM4E B2RXH2 3/20 0.63
HSD17B10 Q99714 3/20 0.63
HPGD P15428 3/20 0.63
KMT2A Q03164 3/20 0.59
CYP3A4 P08684 2/20 0.59
CYP2C9 P11712 2/20 0.59
TRPA1 O75762 2/20 0.59
MEN1 O00255 2/20 0.59
AKR1B10 O60218 1/20 0.59
ABCB11 O95342 1/20 0.59
DHFR P00374 1/20 0.59
LMNA P02545 1/20 0.59
MPO P05164 1/20 0.59
CYP1A2 P05177 1/20 0.59
AKR1B1 P15121 1/20 0.59
PTGS1 P23219 1/20 0.59
PTGS2 P35354 1/20 0.59
AKR1C3 P42330 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29357094 0.98 ALDH1A1 (0.65) ALDH1A1KDM4EHSD17B10HPGDKMT2A
SCHEMBL56188 0.98 ALDH1A1 (0.65) ALDH1A1KDM4EHSD17B10HPGDKMT2A
SCHEMBL6917760 0.95 ALDH1A1 (0.63) ALDH1A1KDM4EHSD17B10HPGDKMT2A
SCHEMBL6914970 0.95 ALDH1A1 (0.63) ALDH1A1KDM4EHSD17B10HPGDKMT2A
Hydrochloric Acid SCHEMBL29441422 0.95 ALDH1A1 (0.63) ALDH1A1KDM4EHSD17B10HPGDKMT2A
SCHEMBL1135931 0.95 ALDH1A1 (0.63) ALDH1A1KDM4EHSD17B10HPGDKMT2A
SCHEMBL6913158 0.95 ALDH1A1 (0.63) ALDH1A1KDM4EHSD17B10HPGDKMT2A
SCHEMBL6915470 0.95 ALDH1A1 (0.63) ALDH1A1KDM4EHSD17B10HPGDKMT2A
Hydrochloric Acid SCHEMBL21381442 0.95 ALDH1A1 (0.63) ALDH1A1KDM4EHSD17B10HPGDKMT2A
Charcoal, Activated SCHEMBL30779743 0.95 ALDH1A1 (0.63) ALDH1A1KDM4EHSD17B10HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103833723-B The manufacture method of cyclic sulfonic acid ester and intermediate thereof 和光纯药工业株式会社 2016-08-17 CN disclosed
EP-2757102-B1 Intermediate for producing a cyclic sulfonic acid ester WAKO PURE CHEM IND LTD (JP) 2016-03-23 EP disclosed
US-8969591-B2 Method for producing cyclic sulfonic acid ester and intermediate thereof WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2015-03-03 US disclosed
EP-2463281-B1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF WAKO PURE CHEM IND LTD (JP) 2014-10-22 EP disclosed
EP-2757102-A1 1,3-propanesultone derivative useful in the preparation of a 1,3-propenesultone derivative Wako Pure Chemical Industries, Ltd. (JP) 2014-07-23 EP disclosed
CN-103833723-A METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF WAKO PURE CHEM IND LTD 2014-06-04 CN disclosed
US-20140142324-A1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2014-05-22 US disclosed
US-8673963-B2 Method for producing cyclic sulfonic acid ester and intermediate thereof WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2014-03-18 US disclosed
CN-102471305-B Process for producing cyclic sulfonic acid ester and intermediate thereof WAKO PURE CHEM IND LTD 2014-01-29 CN disclosed
EP-2463281-A1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF Wako Pure Chemical Industries, Ltd. (JP) 2012-06-13 EP disclosed
US-20120130089-A1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140142324-A1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF STS, TST, SULT1A1 CHRM1 3299/4885ALDH1A1 131/4885KDM4E 3194/4885
US-20120130089-A1 METHOD FOR PRODUCING CYCLIC SULFONIC ACID ESTER AND INTERMEDIATE THEREOF STS, TST, SULT1A1 CHRM1 3299/4885ALDH1A1 131/4885KDM4E 3194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.